| Financial Year |
March 31 2023 |
| Monetary Funds |
993,061,104.67 |
| Held-for-trading Financial Assets |
70,246,873.90 |
| Notes Receivable |
-- |
| Accounts Receivable |
296,490,928.94 |
| Advances to Suppliers |
12,554,541.57 |
| Other Receivables |
2,030,005,229.94 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
106,647,243.28 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
10,833,500.00 |
| Other Current Assets |
28,820,696.63 |
| Total Current Assets |
3,548,660,118.93 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
140,570,125.89 |
| Investment Properties |
86,276,278.56 |
| Fixed Assetes |
13,204,812.93 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
11,191,574.14 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
7,912,470.30 |
| Deferred Income Tax Assets |
9,985,937.39 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
299,283,470.57 |
| Total Assets |
3,847,943,589.50 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
124,982,821.08 |
| Accounts Received In Advance |
7,594,676.40 |
| Employee Compensation Payable |
66,579,724.30 |
| Taxes Payable |
282,524,215.34 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
789,369,238.08 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
2,013,828,140.47 |
| Other Current Liabilities |
1,956,956.57 |
| Sub-Total of Current Liabilities |
3,350,639,052.74 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
993,260.42 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
85,398.21 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
10,341,863.03 |
| Total Liabilities |
3,360,980,915.77 |
| Paid-In Capital(Or Share Stock) |
853,460,723.00 |
| Capital Surplus |
233,554,317.78 |
| Surplus Reserve |
19,881,038.37 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-647,377,234.38 |
| Minority Stockholder's Interest |
27,443,828.96 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
459,518,844.77 |
| Owner's Equity（Stockholder's Equity） |
486,962,673.73 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,847,943,589.50 |
